| Prev Close: | 67.70 |
|---|---|
| Open: | 67.30 |
| Bid: | 68.15 |
| Ask: | 68.20 |
| 1y Target Est: | 55.25 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 67.30 - 69.45 |
|---|---|
| 52wk Range: | 38.55 - 71.00 |
| Volume: | 110,048 |
| Avg Vol (3m): | 40,416 |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Headlines
- Basilea reports presentation of new data on anti-infective drug candidates addressing drug resistanceThomson Reuters ONE(Mon, Apr 29)
- Swiss stocks - Factors to watch on April 10at Reuters(Wed, Apr 10)
- Resolutions of the Ordinary General Meeting of Shareholders of Basilea Pharmaceutica Ltd.Thomson Reuters ONE(Tue, Apr 9)
- Basilea's Board proposes Martin Nicklasson to succeed Chairman Werner Henrich and recommends to shareholders that they do not support the request for a capital distribution at this timeThomson Reuters ONE(Thu, Mar 7)
- CORRECTED-Basilea shareholder requests repayment of capitalat Reuters(Mon, Feb 25)
- Swiss stocks - Factors to watch on Feb 25at Reuters(Mon, Feb 25)
- Basilea shareholder requests repayment of capitalat Reuters(Sat, Feb 23)
- Basilea receives request to place repayment of CHF 48 million from capital contribution reserve on the agenda of the ordinary general meeting of shareholdersThomson Reuters ONE(Fri, Feb 22)
- Kidney-Damaging Drug Seen Attacking Spread of Superbugs: Healthat Bloomberg(Sun, Jun 10)
Press Releases
- Basilea reports presentation of new data on anti-infective drug candidates addressing drug resistanceThomson Reuters ONE(Mon, Apr 29)
- Resolutions of the Ordinary General Meeting of Shareholders of Basilea Pharmaceutica Ltd.Thomson Reuters ONE(Tue, Apr 9)
- Basilea's Board proposes Martin Nicklasson to succeed Chairman Werner Henrich and recommends to shareholders that they do not support the request for a capital distribution at this timeThomson Reuters ONE(Thu, Mar 7)
Reports
- No Reports available for BSLN.SW at this time.